Effect of pneumococcal conjugate vaccination in Uruguay, a middle-income country.
In 2008, a 7-valent pneumococcal conjugate vaccine (PCV7) was introduced into the routine childhood immunization program in Uruguay, with a 2+1 schedule. In 2010, PCV13 replaced PCV7, and the same 2+1 schedule was used. The effect of these pneumococcal vaccines on the incidence of invasive pneumococ...
Main Authors: | Gabriela García Gabarrot, Mariana López Vega, Gabriel Pérez Giffoni, Silvia Hernández, Pablo Cardinal, Viviana Félix, Jean Marc Gabastou, Teresa Camou, Uruguayan SIREVA II Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4223029?pdf=render |
Similar Items
-
Pneumococcal conjugate vaccine implementation in middle-income countries
by: Tricarico, Serena, et al.
Published: (2017) -
Detección de cepas de Neisseria meningitidis resistentes a rifampicina en el Uruguay Detection of rifampicin-resistant strains of Neisseria meningitidis in Uruguay
by: Gabriel Pérez Giffoni, et al.
Published: (2011-12-01) -
Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.
by: María Hortal, et al.
Published: (2014-01-01) -
Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries: A Systematic Review.
by: Kimberly Bonner, et al.
Published: (2015-01-01) -
Economic impact of pneumococcal conjugate vaccination in Brazil, Chile, and Uruguay Impacto económico de la vacuna antineumocócica conjugada en Brasil, Chile y Uruguay
by: Dagna O. Constenla
Published: (2008-08-01)